|
⚲
|
| Keyboard |
| Genextra SpA
✚
|
|
|---|---|
| CIK # | 0001559515 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001559515] | |
| 4 | [0001559515] | |
| SC 13G | [0001559515] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Genextra Spa | Quince Therapeutics Inc | [2023-12-15] |
| Genextra Spa | Intercept Pharmaceuticals Inc | [2013-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Intercept Pharmaceuticals Inc | |
| Genextra SpA |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2020-08-17 | Sell | 126,888 | $50.15 | 6,363,433 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2020-08-17 | Sell | 1,235,512 | $46.75 | 57,760,186 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2020-08-14 | Sell | 54,600 | $50.55 | 2,760,030 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2020-08-13 | Sell | 83,000 | $52.60 | 4,365,800 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2020-05-13 | Sell | 595,578 | $84.60 | 50,385,899 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2018-11-29 | Sell | 750,000 | $105.07 | 78,802,500 |
|
Intercept Pharmaceuticals Inc ICPT
Common stock, par value $0.001 per share
|
2018-04-09 | Buy | 390,625 | $64.00 | 25,000,000 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2014-04-10 | Sell | 30,623 | $293.91 | 9,000,406 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2014-04-10 | Option exercise | 865,381 | $10.40 | 8,999,962 |
|
Intercept Pharmaceuticals Inc ICPT
Warrant to Purchase Common Stock · derivative
|
2014-04-10 | Option exercise | 865,381 | $0.00 | |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock
|
2014-04-09 | Sell | 318,695 | $320.00 | 101,982,400 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock, par value $0.001 per share
|
2013-10-21 | Sell | 124,912 | $62.50 | 7,807,000 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock, par value $0.001 per share
|
2013-10-15 | Sell | 1,123,415 | $62.50 | 70,213,438 |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock, par value $0.001 per share
|
2012-10-16 | Conversion | 2,403,837 | ||
|
Intercept Pharmaceuticals Inc ICPT
Common Stock, par value $0.001 per share
|
2012-10-16 | Conversion | 2,403,837 | ||
|
Intercept Pharmaceuticals Inc ICPT
Series A Preferred Stock · derivative
|
2012-10-16 | Conversion | 13,888,889 | $0.00 | |
|
Intercept Pharmaceuticals Inc ICPT
Series C Preferred Stock · derivative
|
2012-10-16 | Conversion | 4,500,000 | $0.00 | |
|
Intercept Pharmaceuticals Inc ICPT
Series A Preferred Stock · derivative
|
2012-10-16 | Conversion | 13,888,889 | $0.00 | |
|
Intercept Pharmaceuticals Inc ICPT
Common Stock, par value $0.001 per share
|
2012-10-16 | Conversion | 778,843 |